Tag: Targeted therapy

A review of the association between nuclear receptors and ocular diseases

2016, No. 11, Review

Authors：Liu Ke,  Qin Bo,  Zou Chang DOI: 10.3760/cma.j.issn.2095-0160.2016.11.017 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1042-1046. Abstract                              [Download PDF] [Read Full Text] Nuclear receptor is one of abundant transcription factors in human body.Interacted with corresponding ligands, coactivators and corepressors, nuclear receptor can regulate the expression of genes and […]

Research progress of anti-VEGF for the therapy in wet age-related macular degeneration

2018, No. 12, Review

Authors: Liu Shu,  Xu Xiaofang DOI: 10.3760/cma.j.issn.2095-0160.2018.12.013 Published 2018-12-10 Cite as Chin J Exp Ophthalmol, 2018,36(12): 962-966. Abstract                              [Download PDF] [Read Full Text] Age-related macular degeneration (AMD) is the primary cause of the blindness among the population aged more than 50 years old.The […]

Research progress of anti-VEGF for the therapy in wet age-related macular degeneration

2018, No. 12, Review

Authors: Liu Shu,  Xu Xiaofang DOI: 10.3760/cma.j.issn.2095-0160.2018.12.013 Published 2018-12-10 Cite as Chin J Exp Ophthalmol, 2018,36(12): 962-966. Abstract Age-related macular degeneration (AMD) is the primary cause of the blindness among the population aged more than 50 years old.The prevalence of AMD increases with age growing.Wet AMD is the main cause of the visual impairment in over 90% […]